Tag Archives: Antibodies

[ad_1] Top line New research based on early-stage clinical trials shows promising, but conflicting results for Sinovac Biotech’s CoronaVac Covid-19 vaccine, which is capable of generating a “rapid” immune response in individuals but has produced lower than those recorded in people who had recovered from Covid-19. Sinovac Biotech reported Phase …

[ad_1] Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 in Wuhan, China, and has rapidly progressed into a devastating pandemic affecting global public health and paralyzing economies. So far, the COVID-19 pandemic has caused over 55.4 million infections and over 1.33 million …

[ad_1] The kit used by medical staff in the UK and the EU involves drawing a small amount of blood from the finger or vein to detect antibodies, particularly specific proteins that respond to infection. While it’s fast – results appear in less than 20 minutes – it doesn’t cause …

[ad_1] The 2019 coronavirus disease (COVID-19) pandemic calls for better and faster tests to ensure more accurate diagnosis, monitoring and surveillance of the disease and its spread. Serological testing is used to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection after the acute phase. A new study published on …

[ad_1] Children with coronavirus disease 2019 (COVID-19) sometimes develop multisystem inflammatory syndrome in children (MIS-C), which is associated with high morbidity. The underlying mechanism associated with T cells is described by the researchers in a new study published on the prepress server bioRxiv* in November 2020, in response to superantigen …

[ad_1] A study conducted at the United States Army Research Institute of Infectious Diseases shows how a relatively simple full-length DNA vaccine against the spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can elicit a neutralizing antibody response in a animal model – even after a single shot …

[ad_1] Using a number of different monoclonal antibodies, the researchers determined several mutations in the SARS-CoV-2 spike protein that leads to resistance. Understanding these resistant mutations is important for the development of effective therapeutic strategies. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the COVID-19 pandemic, infects host cells …

[ad_1] The FDA has approved emergency use of the only drug Eli Lilly that contains anti-corona virus antibodies for the treatment of patients with mild or moderate COVID-19. The Daily Mail newspaper said the drug will begin shipping immediately and will be assigned to states on a weekly basis based …

[ad_1] Most vaccine research in the current 2019 coronavirus (COVID-19) pandemic has focused on the role of the angiotensin converting enzyme 2 (ACE2) receptor in mediating viral entry into the host cell. However, a recent study published on the prepress server bioRxiv* in November 2020 discovers the major role played …

[ad_1] A study by Imperial College London that analyzed the prevalence of antibodies in 365,104 adults in England between the last months of June and September found that the level of protection against coronavirus among those who had covid-19 decreased “very rapidly”, since the immunity provided by the antibodies could …